CAPLACIZUMAB-YHDP vs CAPREOMYCIN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
CAPLACIZUMAB-YHDP vs CAPREOMYCIN: Safety Overview
| Metric | CAPLACIZUMAB-YHDP | CAPREOMYCIN |
|---|---|---|
| Total FAERS Reports | 1,397 | 398 |
| Deaths Reported | 59 | 107 |
| Death Rate | 4.2% | 26.9% |
| Hospitalizations | 270 | 148 |
| Average Patient Age | 46.1 yrs | 36.1 yrs |
| % Female Patients | 70.4% | 49.5% |
| FDA Approval Date | N/A | Approved Prior to Jan 1, 1982 |
| Marketing Status | Prescription | Discontinued |